Cationic liposomes as gene transfer vectors: Barriers to successful application in gene therapy

Current Opinion in Molecular Therapeutics

Volumn 1, Issue 2, 1999, Pages 147-157

  Simões, Sérgio ^a,c   Pires, Pedro ^c   Düzgünes, Nejat ^d   Pedroso De Lima, Maria C ^b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; LIPOSOME; VIRUS VECTOR;

ANIMAL MODEL; ARTICLE; BIOTECHNOLOGY; CELL INTERACTION; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC MANIPULATION; IN VITRO STUDY; INTRACELLULAR TRANSPORT; NONHUMAN;

ANIMALS; CATIONS; CLINICAL TRIALS; GENE THERAPY; GENETIC VECTORS; LIPOSOMES; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

ANIMALIA;

EID: 0037856537     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Hug P, Sleight RG: Liposomes for the transformation of eukaryotic cells. Biochim Biophys Acta (1991) 1097:1-17.
2. Philip R, Liggitt D, Philip M, Dazin P, Debs R: In vivo gene delivery: efficient transfection of T lymphocytes in adult mice. J Biol Chem (1993) 268:16087-16090.
3. Singhal A, Huang L: Gene transfer in mammalian cells using liposomes as carriers. In: Gene Therapeutics: Methods and Applications of Direct Gene Tansfer. Wolf JA (Ed), Birkhäuser, Boston (1994):118-142.
4. Thierry AR, Lunardi-Iskandar Y, Bryant JL, Rabinovich P, Gallo RC, Mahan LC: Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc Natl Acad Sci USA (1995) 92:9742-9746.
5. Felgner PL, Tsai YJ, Sukhu L, Wheeler CJ, Manthorpe M, Marshall J, Cheng SH: Improved cationic lipid formulations for in vivo gene therapy. Ann NY Acad Sci (1995) 772:126-139.
6. Lasic DD, Templeton NS: Liposomes in gene therapy. Adv Drug Deliv Rev (1996) 20:221-266.
7. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ: Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem (1995) 270:18997-19007. The results described allow the identification of a number of steps at which lipid-mediated transfection is inefficient. According to their data, a large amount of DNA is delivered to the cell, a small percentage of that is released from the endosome, and a small percentage of that makes its way from the cytoplasm to the nucleus where it is transcribed. The inefficiency of each step suggests that specific attention must be paid to developing ways to overcome each of the different barriers.
8. Xu Y, Szoka FC Jr: Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry (1996) 35:5616-5622. The authors investigated which biomolecules interfere and mediate release of DNA from a complex with cationic liposomes. They demonstrated that anionic lipids normally found on the cytoplasmic-facing monolayer of cell membranes can very potently displace DNA from the cationic liposome/DNA complex. On the basis of their results, the authors proposed a mechanistic model to explain the release of DNA from the cationic liposome complex in cells.
9. Konopka K, Pretzer E, Felgner PL, Düzgünes N: Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxity by cationic liposomes. Biochim Biophys Acta (1996) 1312:186-196.
10. Konopka K, Harrison GS, Felgner PL, Düzgünes N: Cationic liposome-mediated expression of HIV-regulated luciferase and diphtheria toxin A genes in HeLa cells infected with or expressing HIV. Biochim Biophys Acta (1997) 1356:185-197.
11. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA (1987) 84:7413-7417.
12. Ciccarone V, Hawley-Nelson P, Jessee J: Cationic liposome-mediated transfection: effect of serum on expression and efficacy. Focus (1993) 15:80-83.
13. Li S, Huang L: Lipidic supramolecular assemblies for gene transfer. J Liposome Res (1996) 6:589-608.
14. Gustaffson J, Arvidson G, Karlsson G, Almgren M: Complexes between cationic liposomes and DNA visualized by cryo-TEM. Biochim Biophys Acta (1995) 1235:305-312.
15. Radler JO, Koltover I, Salditt T, Safinya CR: Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science (1997) 275:810-814. This work provides important insights into the interactions established between DNA and cationic liposomes as well as into the structure of the resulting lipid/DNA complexes. By carrying out a combined in situ optical microscopy and X-ray diffraction study, the authors conclude that the complexes consist of a higher ordered multilamellar structure with DNA sandwiched between cationic lipid bilayers. These findings may lead to a better understanding of the important structural parameters relevant to transfection efficiencies in gene therapy.
16. Lasic DD, Strey H, Stuart MCA, Podgomick R, Frederick PM: The structure of DNA-liposome complexes. J Am Chem Soc (1997) 119:832-833.
17. Dan N: Multilamellar structures of DNA complexes with cationic liposomes. Biophys J (1997) 73:1842-1846.
18. Dan N: The structure of DNA complexes with cationic liposomes-cylindrical or flat bilayers? Biochim Biophys Acta (1998) 1369:34-38.
19. May S, Ben-Shaul A: DNA-lipid complexes: stability of honeycomb-like and spaghetti-like structures. Biophys J (1997) 73:2427-2440.
20. u) of cationic liposome-DNA complexes, respectively. The authors correlate the self-assembled structure of cationic liposome-DNA complexes with their colloidal stability and ability to mediate transfection. Based on their findings, the authors rationalize the choice of the 'helper' lipid in the cationic liposomes.
21. Sternberg B, Sorgi FL, Huang L: New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett (1994) 356:361-366.
22. Ferrari ME, Nguyen CM, Zelphati O, Tsal Y, Felgner PL: Analytical methods for the characterization of cationic lipid-nucleic acid complexes. Hum Gene Ther (1998) 9:341-351.
23. Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner PL: Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem (1994) 269:2550-2561.
24. Lee ER, Marshall J, Siegel CS, Jiang C, Yew NS, Nichols MR, Nietupski JB, Ziegler RJ, Lane MB, Wang KX, Wan NC, Scheute RK, Harris DJ, Smith AE, Cheng SH: Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther (1996) 7:1701-1717. This paper reports on the structures of several novel cationic lipids that are effective for gene delivery to the lungs of mice. It was shown that an amphiphile (#67) consisting of a cholesterol anchor linked to a spermine headgroup in a 'T-shape' configuration is as efficient for gene transfer to the lung as adenovirus vectors without eliciting a host immune response.
25. Scheule RK, George JA, Bagley RG, Marshall J, Kaplan JM, Akita GY, Wang KX, Lee ER, Harris DJ, Jiang C, Yew NS, Smith AE, Cheng SH: Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum Gene Ther (1997) 8:689-707.
26. Hui SW, Langner M, Zhao Y-L, Hurley E, Chan K: The role of helper lipids in cationic liposome-mediated gene transfer. Biophys J (1996) 71:590-599.
27. Mok KWC, Cullis PR: Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys J (1997) 73:2534-2545.
28. Simões S, Slepushkin V, Gaspar R, Pedroso de Lima MC, Düzgünes N: Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther (1998) 5:955-964.
29. Zuidan NJ, Barenholz Y: Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery. Biochim Biophys Acta (1998) 1369:34-38.
30. Liu Y, Mounkes LC, Liggitt HD, Brown CS, Solodin I, Heath TD, Debs RJ: Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat Biotech (1997) 15:167-173. These authors characterized extensively the relationships between the design of cationic liposomes and their in vivo behavior to mediate transfection. Incorporation of cholesterol in multilamellar liposomes significantly increased the expression levels of different trangenes, which was attributed to a prolonged circulation time of injected lipoplexes and increased uptake and retention in tissues.
31. Hong K, Zheng W, Baker A, Papahadjopoulos D: Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett (1997) 400:233-237.
32. Song YK, Liu D: Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration. Biochim Biophys Acta (1998) 1372:141-150.
33. Wang J, Guo X, Xu Y, Barron L, Szoka FC Jr: Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. J Med Chem (1998) 41:2207-2215.
34. Solodin I, Brown CS, Bruno MS, Chow CY, Jang EH, Debs RJ, Heath TD: A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. Biochemistry (1995) 34:13537-13544.
35. Wheeler CJ, Felgner PL, Tsai Y, Marshall J, Shukhu L, Doh SG, Hartikka J, Nietupski JB, Manthrope M, Nichols M, Plewe M, Liang X, Norman J, Smith A, Cheng SH: A novel cationic lipid reagent greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci USA (1996) 93:11454-11459.
36. Paukku T, Lauraeus S, Huhtaniemi I, Kinnunen PK: Novel cationic liposomes for DNA-transfection with high efficiency and low toxicity. Chem Phys Lipids (1997) 87:53-29.
37. Gorman CM, Aikawa M, Fox B, Fox E, Lapuz C, Michaud B, Nguyen H, Roche E, Sawa T, Wiener-Kronish JP: Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC. Gene Ther (1997) 4:983-992.
38. Yew NS, Wysokenski DM, Wang KX, Ziegler RJ, Marshall J, McNeilly D, Cherry M, Osbum W, Cheng SH: Optimization of plasmid vectors for high level expression in lung epithelial cells in vitro and in vivo. Hum Gene Ther (1997) 8:575-584.
39. Tomlinson E, Rolland AP: Controllable gene therapy: pharmaceutics of non-viral gene delivery systems. J Control Rel (1996) 39:357-372.
40. Eastman SJ, Siegel C, Tousignant J, Smith AE, Cheng SH, Scheule RK: Biophysical characterization of cationic lipid:DNA complexes. Biochim Biophys Acta (1997) 1325:41-62.
41. Pires P, Simões S, Nir S, Gaspar R, Düzgünes N, Pedroso de Lima MC: Interaction of cationic liposomes and their DNA complexes with monocytic leukemia cells. Biochim Biophys Acta (1999) in press. The relationship between the characteristics of the lipoplexes, their mode of interaction with cells and their ability to mediate transfection was investigated. By monitoring the dequenching of a non-exchangeable fluorescent probe embedded in the liposome membrane, the authors assessed the effects of the lipid/DNA charge ratio, endocytosis inhibitors and serum on membrane lipid mixing. The authors conclude that no correlation between fusion with the plasma membrane and transfection can be established. This lack of correlation was also reported by others [61].
42. Ledley FD: Pharmaceutical approach to somatic gene therapy. Pharm Res (1996) 13:1595-1614.
43. Mahato IR, Rolland A, Tomlinson E: Cationic lipid-based gene delivery systems: pharmaceutical perspectives. Pharm Res (1997) 14:853-859.
44. Zelphati O, Nguyen C, Ferrari M, Felgner J, Tsai Y, Felgner PL: Stable and monodisperse lipoplex formulations for gene delivery. Gene Ther (1998) 5:1272-1282. A careful and systematic study to identify and characterize monodisperse stable lipoplex formulations is reported. A novel methodology allowing the preparation of stable lipoplexes with high transfection activities in a reproducible manner without addition of any other components was described. Furthermore, a physically stable isotonic formulation is presented, which may be useful as a practical clinical product.
45. Smith JG, Wedeking T, Vernachio JH, Way H, Niven RW: Characterization and in vivo testing of a heterogeneous cationic lipid-DNA formulation. Pharm Res (1998) 15:1356-1363.
46. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN: Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nature Biotech (1997) 15:647-652. Significantly enhanced systemic delivery and gene expression were observed with extruded cationic liposomes containing cholesterol. A high efficiency of gene delivery in vivo and the broad tissue distribution of the lipoplexes observed were attributed to a homogeneous population of complexes which exhibited a novel morphology involving condensation of DNA in the interior of invaginated liposomes between two lipid bilayers (proposed model).
47. Deshpande D, Blezinger P, Pillai R, Duguid J, Freimark B, Rolland A: Target specific optimization of cationic lipid-based systems for pulmonary gene therapy. Pharm Res (1998) 15:1340-1347.
48. Yang JP, Huang L: Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome and DNA. Gene Ther (1997) 4:950-960.
49. Lasic DD: Recent developments in medical applications of liposomes: sterically stabilized liposomes in cancer therapy and gene delivery in vivo. J Control Rel (1997) 48:203-222.
50. Koe GS, Way HL, Quetingco GM, Smith JG, Wedeking T, Niven RW: The effect of mixing on the formation of DNA/liposome complexes. Pharm Res (1997) 14:857.
51. Liu F, Qi H, Huang L, Liu D: Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther (1997) 4:517-523.
52. Yang JP, Huang L: Time-dependent maturation of cationic liposome-DNA complex for serum resistance. Gene Ther (1998) 5:380-387.
53. Liu F, Yang J, Huang L, Liu D: New cationic lipid formulations for gene transfer. Pharm Res (1996) 13:1856-1860.
54. Zhang YP, Reimer DL, Zhang G, Lee PH, Bally MB: Self-assembling DNA-lipid-particles for gene transfer. Pharm Res (1997) 14:190-196. See annotation to [55••].
55. Hofland HEJ, Shephard L, Sullivan SM: Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci USA (1996) 93:7305-7309. This report describes a new methodology that leads to the formation of stable cationic lipid/DNA complexes that maintain the same transfection efficiency for up to three months and that can be concentrated with no loss in activity. Briefly, this new procedure involves the solubilization of cationic liposomes with 1% octytglucoside and complexation of plasmid DNA with the lipid in the presence of detergent. The stable complexes were obtained after removal of the detergent by dialysis. This study, as well as that presented in reference [54•], provides an important contribution to the development of alternative approaches to the use of cationic liposomes as gene carriers.
56. Hofland HEJ, Nagy D, Liu J-J, Spratt K, Lee Y-L, Danos O, Sullivan SM: In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex. Pharm Res (1997) 14:742-749.
57. Anchordoquy TJ, Girouard LG, Carpenter JF, Kroll DJ: Stability of lipid/DNA complexes during agitation and freeze-thawing. J Pharm Sci (1998) 87:1046-1051. A comprehensive study on the stability of lipid/DNA complexes during physical stresses encountered during shiping and storage. This study addresses a crucial issue for the pharmaceutical development of lipid-based gene delivery systems (see also reference [58]).
58. Anchordoquy TJ, Carpenter JF, Kroll DJ: Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration. Arch Biochem Biophys (1997) 348:199-206.
59. Friend DS, Papahadjopoulos D, Debs RJ: Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim Biophys Acta (1996) 1278:41-50.
60. Wrobel I, Collins D: Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim Biophys Acta (1995) 1235:296-304.
61. Stegmann T, Legendre JY: Gene transfer mediated by cationic lipids: lack of a correlation between lipid mixing and transfection. Biochim Biophys Acta (1997) 1325:71-79.
62. Van der Woude I, Visser HW, Ter Beest MBA, Wagenaar A, Ruiters MHJ, Engberts JBFN, Hoekstra D: Parameters influencing the introduction of plasmid DNA into cells by the use of synthetic amphiphiles as a carrier system. Biochim Biophys Acta (1995) 1240:34-40.
63. Noguchi A, Furuno T, Kawaura C, Nakanishi M: Membrane fusion plays an important role in gene transfection mediated by cationic liposomes. FEBS Lett (1998) 433:169-173.
64. Page RL, Butler SP, Subramamian A, Gwazdauskas FC, Johnson JL, Velander WH: Transgenesis in mice by cytoplasmic injection of polylysine/DNA mixtures. Trangenic Res (1995) 4:353-360.
65. Cheng PW: Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum Gene Ther (1996) 7:275-282. This paper describes a high efficiency, non-viral gene transfer method employing cationic liposomes plus a receptor ligand. This protocol results in 100% transfection of cells when lipofectin is associated with transferrin. The enhancement of liposome-mediated gene transfer efficiency and expression by transferrin was shown to vary among different cationic liposomes. Similar strategies were also reported in references [28,66•], although such a high efficiency of transfection could not be reproduced.
66. Simões S, Slepushkin V, Gaspar R, Pedroso de Lima MC, Düzgünes N: Transfection of human macrophages by lipoplexes via the combined use of targeting ligands and fusogenic peptides. J Leuk Biol (1999) in press. A combination strategy involving cationic liposomes to condense and carry DNA, transferrin to facilitate cellular uptake, and the pH-sensitive peptide GALA to promote endosome destabilization, resulted in significant expression of a luciferase gene in primary human macrophages. Transfection of these cells was dependent on the degree of differentiation of the cells. The quaternary complexes of cationic liposomes, DNA, transferrin and GALA exhibited a net negative charge, which may obviate a limitation of cationic synthetic vectors in vivo. The lack of cytotoxicity and the expected lack of immunogenicity of these complexes may render them useful for gene delivery to macrophages in vivo. In this context see also references [28,65••].
67. Remy JS, Kichler A, Mordinov V, Schuber F, Behr JP: Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc Natl Acad Sci USA (1995) 92:1744-1748.
68. Kao GY, Change LJ, Allen TM: Use of targeted cationic liposomes in enhanced DNA delivery to cancer cells. Cancer Gene Ther (1996) 3:250-256.
69. Hart SL, Arancibia-Carcamo CV, Wolfert MA, Mailhos C, O'Reilly NJ, Ali RR, Coutelle C, George AJ, Arbottle RP, Knight AM, Larkin DF, Lewinsky RJ, Seymour LW, Trasher AJ, Kinnon C: Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum Gene Ther (1998) 9:575-585. This work reports on non-viral vectors consisting of lipofectin/integrin-binding peptide/DNA complexes (LID) and demonstrates their potential for application in gene therapy. A significant enhancement of both transfection activity and efficiency was observed as compared to that for integrin-targeting peptide/DNA (ID). According to the authors, such an enhancement results from promotion of internalization and endosome destabilization.
70. Maurer N, Mui B, Mok KWC, Akhong QF, Cullis PR: Lipid-based systems for the intracellular delivery of genetic drugs. Mol Memb Biol (1999) in press.
71. Gao X, Huang L: Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry (1996) 35:1027-1036.
72. Sorgi FL, Bhattacharya S, Huang L: Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther (1997) 4:961-968.
73. Li S, Huang L: In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther (1997) 4:891-900.
74. Li S, Rizzo MA, Bhattacharya S, Huang L: Characterization of cationic lipid-protamine-DNA (LPO) complexes for intravenous gene delivery. Gene Ther (1998) 5:930-937. A novel lipid-based formulation consisting of cationic lipid, protamine sulfate (a USP compound) and DNA which proved to be highly efficient in mediating transfaction both in vitro and in vivo was extensively characterized. This work emerges from a series of previous studies that explored the possibility of using cationic polypeptides in association with cationic liposomes, aiming at condensing and protecting DNA and promoting its delivery (see references [71-73]).
75. Csermely P, Schnaider T, Szántó I: Signalling and transport through the nuclear membrane. Biochim Biophys Acta (1995) 1241:425-452.
76. Aronsohn AI, Hughes JA: Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy. J Drug Targeting (1997) 5:163-169. These authors developed a novel non-viral delivery vehicle involving the association of NLS peptides to cationic liposome/DNA complexes. The main goal of this approach was to promote nuclear DNA delivery, thus overcoming the major barrier faced by transfection mediated by lipoplexes. Although the authors demonstrate that the use of such strategy leads to a significant enhancement of transgene expression, it remains to be clarified whether this effect resulted from an increase of DNA delivery into the nucleus.
77. Crook K, Stevenson BJ, Dubochet M, Porteous DJ: Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum. Gene Ther (1998) 5:137-143.
78. Egilmez NK, Iwanuma Y, Bankert RB: Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer. Biochem Biophys Res Commun (1996) 221:169-173.
79. Plank C, Mechtler K, Szoka FC Jr, Wagner E: Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther (1996) 7:1437-1446.
80. Zelphati O, Uyechi LS, Barron LG, Szoka FC Jr: Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim Biophys Acta (1998) 1390:119-133. In this report evidence was presented that serum components can decrease ODN delivery into cells by changing the physicochemical properties of cationic lipid/ODN complexes and by dissociating the complex. Based on the finding that bovine serum albumin (BSA) can protect the complex against dissociation from certain polyanions present in serum, the authors suggest the possibility that BSA can be used to coat the preformed cationic complex to protect it from interaction with other species.
81. Song YK, Liu F, Chu S, Liu D: Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther (1997) 8:1585-1594.
82. Sternberg B, Hong K, Zheng W, Papahadjopoulos D: Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo. Biochim Biophys Acta (1998) 1375:23-35.
83. Papahadjopoulos D: Stealth® liposomes: from steric stabilization to targeting. In: Stealth Liposomes. Lasic D, Martin F (Eds), CRC Press, Boca Raton (1995):1-7.
84. Slepushkin VA, Simões S, Dazin P, Newman M S, Guo LS, Pedroso de Lima MC, Düzgünes N: Sterically stabilized pH-sensitive liposomes: intracellular delivery of aqueous contents and prolonged circulation in vivo. J Biol Chem (1997) 272:2382-2388.
85. Meyer O, Kirpotin D, Hong K, Sternberg B, Park JW, Woodle MC, Papahadjopoulos D: Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J Biol Chem (1998) 273:15621-15627. This work describes the potential of using cationic liposomes composed of a cationic lipid (DOTAP, DOGS, DDAB), a neutral lipid (DOPE) and a phospholipid derivative of poly(ethylene glycol) (PEG-PE) to prepare complexes with oligonucleotides (ODN) aimed at enhancing their biological activity. It was demonstrated that modification with PEG-PE not only increases particle stability of cationic liposome-ODN complexes but also allows extraordinarily high loading of ODN, resulting in neutral or negatively charged particles. Of great relevance is the finding that conjugation of antibody fragments recognizing the HER2 receptor to such cationic liposome-ODN complexes triggers efficient delivery of ODN to their sites of action, resulting in enhanced biological activity of antisense ODN in a target-specific manner.
86. Uster PS, Allen TM, Daniel BE, Mendez CJ, Newman MS, Zhu GZ: Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged circulation time. FEBS Lett (1996) 386:243-246. The authors demonstrate that methoxy-PEG-distearoylphosphatidylethanolamine (mPEG-DSPE) can be inserted into lipid vesicles composed of lecithin/cholesterol, resulting in external surface PEG-grafted liposomes with physical and biological characteristics similar to those of liposomes obtained by hydration-extrusion of the mixture of all the lipids.
87. Zalipsky S, Mullah N, Harding JA, Gittelman J, Guo L, DeFrees SA: Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. Bioconjugate Chem (1997) 8:11-118. Based on recent findings (see annotation of reference [86•]), the authors devised an improved method for formulation of ligand-bearing polymer-grafted liposomes which contain ligand-polymer components exclusively on the outer leaflet of the lipid bilayer. This new method overcomes the limitations of previously described approaches to ligand-bearing PEG liposomes and holds great promise in development of long-circulating liposomes carrying biologically active ligands on their exterior (see annotation to [86•]).